Description
Nitrogranulong Tablets with Prolonged Release 2.9 mg
Ingredients:
- Each tablet contains 2.9 mg of Nitrogranulong with prolonged release.
Dosage:
- The recommended dosage is one tablet per day, or as directed by a healthcare professional.
Indications:
- Nitrogranulong tablets are indicated for the prevention and treatment of angina pectoris.
Contraindications:
- Do not use Nitrogranulong tablets if you are allergic to any of the ingredients.
- Consult your doctor before use if you have hypotension or severe anemia.
Directions:
- Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.
Scientific Evidence:
- Nitrogranulong tablets with prolonged release 2.9 mg have been studied in clinical trials to assess their efficacy in the management of angina pectoris.
- Research published in the Journal of Cardiology demonstrated that nitroglycerin, the active ingredient in Nitrogranulong, effectively reduces the frequency and severity of angina attacks.
Additional Information:
- Nitrogranulong tablets provide a sustained release of nitroglycerin, ensuring a continuous therapeutic effect over an extended period.
- This formulation helps maintain consistent nitric oxide levels in the body, leading to vasodilation and improved blood flow to the heart muscle.
- Clinical studies have shown that prolonged-release nitroglycerin formulations like Nitrogranulong offer better symptom control and enhanced quality of life for patients with angina.
